Good Mood Foods

Autor: Deshmukh Gp, Jayraj Rao K, Kate Pe, Datir Rp

Publikováno v: Journal of Nutritional Health & Food Engineering. 7

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::94499ab73ade03ff915fa13a04194188
https://doi.org/10.15406/jnhfe.2017.07.00246

Author Correction: SARS-CoV-2 evolution during treatment of chronic infection.

Autor: Kemp SA; Division of Infection and Immunity, University College London, London, UK., Collier DA; Division of Infection and Immunity, University College London, London, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Datir RP; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Ferreira IATM; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Gayed S; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Jahun A; Department of Pathology, University of Cambridge, Cambridge, UK., Hosmillo M; Department of Pathology, University of Cambridge, Cambridge, UK., Rees-Spear C; Division of Infection and Immunity, University College London, London, UK., Mlcochova P; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Lumb IU; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK., Roberts DJ; NHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK., Chandra A; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Temperton N; Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Canterbury, UK., Sharrocks K; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Blane E; Department of Medicine, University of Cambridge, Cambridge, UK., Modis Y; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Leigh KE; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Briggs JAG; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., van Gils MJ; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Smith KGC; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Cambridge Bioresource, Cambridge, UK., Smith C; Department of Virology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Doffinger R; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK., Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK., Barcenas-Morales G; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.; FES-Cuautitlán, UNAM, Cuautitlán Izcalli, Mexico., Pollock DD; Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, USA., Goldstein RA; Division of Infection and Immunity, University College London, London, UK., Smielewska A; Department of Pathology, University of Cambridge, Cambridge, UK.; Department of Virology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Skittrall JP; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.; Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge, UK., Gouliouris T; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Goodfellow IG; Department of Pathology, University of Cambridge, Cambridge, UK., Gkrania-Klotsas E; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK., Illingworth CJR; Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., McCoy LE; Division of Infection and Immunity, University College London, London, UK., Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.; Africa Health Research Institute, Durban, South Africa. rkg20@cam.ac.uk.

Publikováno v: Nature [Nature] 2022 Aug; Vol. 608 (7922), pp. E23.

Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria.

Autor: El Bouzidi K; Division of Infection & Immunity, University College London, London, UK.; Institute for Global Health, University College London, London, UK., Datir RP; Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, UK., Kwaghe V; University of Abuja Teaching Hospital, Abuja, Nigeria., Roy S; Division of Infection & Immunity, University College London, London, UK., Frampton D; Division of Infection & Immunity, University College London, London, UK.; Farr Institute of Health Informatics Research, University College London, London, UK., Breuer J; Division of Infection & Immunity, University College London, London, UK., Ogbanufe O; U.S. Centers for Disease Control and Prevention, U.S. Embassy, Abuja, Nigeria., Murtala-Ibrahim F; Institute of Human Virology Nigeria, Abuja, Nigeria., Charurat M; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, USA., Dakum P; Institute of Human Virology Nigeria, Abuja, Nigeria., Sabin CA; Institute for Global Health, University College London, London, UK., Ndembi N; Institute of Human Virology Nigeria, Abuja, Nigeria.; Africa Centres for Disease Control and Prevention, African Union Commission, Addis Ababa, Ethiopia., Gupta RK; Cambridge Institute of Therapeutic Immunology and Infectious Diseases, University of Cambridge, Cambridge, UK.; Africa Health Research Institute, Durban, South Africa.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2022 Feb 02; Vol. 77 (2), pp. 474-482.

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.

Autor: Collier DA; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Ferreira IATM; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Meng B; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Datir RP; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., Walls AC; Department of Biochemistry, University of Washington, Seattle, WA, USA., Kemp SA; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK.; Division of Infection and Immunity, University College London, London, UK., Bassi J; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Pinto D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Silacci-Fregni C; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Bianchi S; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA, USA., Bowen J; Department of Biochemistry, University of Washington, Seattle, WA, USA., Culap K; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Jaconi S; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Snell G; Vir Biotechnology, San Francisco, CA, USA., Pizzuto MS; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Pellanda AF; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland., Garzoni C; Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland., Riva A; Division of Infectious Diseases, Luigi Sacco Hospital, University of Milan, Milan, Italy., Elmer A; NIHR Cambridge Clinical Research Facility, Cambridge, UK., Kingston N; NIHR Bioresource, Cambridge, UK., Graves B; NIHR Bioresource, Cambridge, UK., McCoy LE; Division of Infection and Immunity, University College London, London, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK.; Department of Medicine, University of Cambridge, Cambridge, UK., Bradley JR; Department of Medicine, University of Cambridge, Cambridge, UK.; NIHR Bioresource, Cambridge, UK., Temperton N; University of Kent, Canturbury, UK., Ceron-Gutierrez L; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK., Barcenas-Morales G; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.; Laboratorio de Inmunologia, UNAM, Cuautitlán, Mexico., Harvey W; Institute of Biodiversity, University of Glasgow, Glasgow, UK., Virgin HW; Vir Biotechnology, San Francisco, CA, USA., Lanzavecchia A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Piccoli L; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland., Doffinger R; Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Wills M; Department of Medicine, University of Cambridge, Cambridge, UK., Veesler D; Department of Biochemistry, University of Washington, Seattle, WA, USA., Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland. dcorti@vir.bio., Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge, UK. rkg20@cam.ac.uk.; Department of Medicine, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. rkg20@cam.ac.uk.; University of KwaZulu Natal, Durban, South Africa. rkg20@cam.ac.uk.; Africa Health Research Institute, Durban, South Africa. rkg20@cam.ac.uk.; Department of Infectious Diseases, Cambridge University Hospitals NHS Trust, Cambridge, UK. rkg20@cam.ac.uk.

Publikováno v: Nature [Nature] 2021 May; Vol. 593 (7857), pp. 136-141. Date of Electronic Publication: 2021 Mar 11.

Optimization of recombination of milk at different fat levels in a small volume universal disperser unit.

Autor: Datir RP; Dairy Engineering Section, SRS, ICAR-National Dairy Research Institute, Bengaluru, India., Ravindra MR; Dairy Engineering Section, SRS, ICAR-National Dairy Research Institute, Bengaluru, India., Manjunatha M; College of Agriculture Engineering, GKVK, UAS, Bengaluru, India., Sharma M; Dairy Engineering Section, SRS, ICAR-National Dairy Research Institute, Bengaluru, India.

Publikováno v: Journal of food science and technology [J Food Sci Technol] 2021 Apr; Vol. 58 (4), pp. 1389-1400. Date of Electronic Publication: 2020 Jul 21.